Login Get Started
Browse
Shares
Healthcare
Pharmaceuticals
Luye Pharma
Luye Pharma logo

2186 - Luye Pharma Share News

HK$5.47 0.2  4.4%

Last Trade - 8:08am

Sector
Healthcare
RiskRating
Speculative
Size
Mid Cap
Style
Style Neutral
Market Cap £1.60bn
Enterprise Value £2.04bn
Revenue £678.0m
Position in Universe 655th / 6135
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions 2186 Dividends
All News
All News Reuters News Company Announcements
BRIEF-Luye Pharma Group Says Clinical Trial Application Of LY01015 Has Been Formally Accepted By CDE Of NMPA
Thu 2:43pm News
BRIEF-Luye Pharma Says Unit Entered Into An Exclusive Agreement
18th Feb News
BRIEF-Luye Pharma Group To Issue Certain New Shares Of Co To A Potential Investor
29th Jan News
BRIEF-Luye Pharma Says Group Of Investors Agreed To Invest RMB194.8 Mln In Shandong Boan
25th Jan News
BRIEF-Luye Pharma Says NMPA Approved Marketing Registration Of Risperidone Microspheres For Injection
14th Jan News
BRIEF-Luye Pharma Group Announces Third Parties' Investments In Shandong Boan Biological Technology
4th Jan News
BRIEF-Luye Pharma Group Says Injection Ly03009 Commenced Phase I Clinical Trial In Australia
4th Jan News
BRIEF-Luye Pharma Announces Inclusion Of Lipusu In New Catalogue Of National Reimbursement Drug List
28th Dec '20 News
BRIEF-Luye Pharma Announces Investment In Shandong Boan Biological Technology
28th Dec '20 News
BRIEF-Pharma Mar And Luye Pharma Have Started Phase I Clinical Trial With Lurbinectedin In China
1st Dec '20 News
BRIEF-Luye Pharma Group Gets Approval Of Initiating Clinical Trial With Denosumab Biosimilar Candidate (Ly06006/Ly01011) In Europe
23rd Oct '20 News
BRIEF-Luye Pharma Gets Clinical Trial Approval For Rivastigmine Multi-Day Transdermal Patch In China
1st Sep '20 News
BRIEF-Luye Pharma Group Says HY Profit Attributable RMB 539.4 Mln
27th Aug '20 News
BRIEF-Luye Pharma Group Announces Approval For Clinical Trial For LPM4870108 Tablets In China
27th Aug '20 News
BRIEF-Luye Pharma Group Gets Approval For Clinical Trial For Lurbinectedin (Ly01017) In China
26th Aug '20 News
BRIEF-Pharma Mar's Lurbinectedin Receives Acceptance For Clinical Trial Application In China
29th Jun '20 News
BRIEF-Luye Pharma Group Says Clinical Trial Application Of Lurbinected Accepted By CDE Of PRC
29th Jun '20 News
BRIEF-Luye Pharma Group Gets Acceptance For Clinical Trial Application Of LPM4870108 Tablets
23rd Jun '20 News
BRIEF-Luye Pharma Group Says IND Application Of LY03013 Accepted By CDE In China
18th Jun '20 News
BRIEF-Luye Pharma Group Says Clinical Trial Application Of Injection Accepted
11th Jun '20 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.